1.46

7.01% -0.11

After Hours: 1.42 -0.04 -2.74%

Dermata Therapeutics Inc (DRMA)

Overview News Price History Financials Discussions Forecast Stock Split

Dermata Therapeutics Inc stock is traded at $1.46, with a volume of 413.97K. It is down -7.01% in the last 24 hours and up +10.61% over the past month. Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Previous Close:

$1.57

Open:

$1.47

24h Volume:

413.97K

Relative Volume:

0.75

Market Cap:

$5.87M

Revenue:

Net Income/Loss:

$-7.10M

P/E Ratio:

-0.2752

EPS:

-5.3059

Net Cash Flow:

$-8.30M

1W Performance:

+32.73%

1M Performance:

+10.61%

6M Performance:

+13.18%

1Y Performance:

-74.87%

1-Day Range:

$1.40

$1.55

1-Week Range:

$1.06

$1.62

52-Week Range:

$0.9509

$6.2248

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name

Dermata Therapeutics Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

(858)-223-0882

Address

3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

DRMA's Discussions on Twitter

Compare DRMA vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRMA Dermata Therapeutics Inc	1.46	5.55M	0	-7.10M	-8.30M	-5.3059
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Dermata Therapeutics Inc Stock (DRMA) Latest News

Aug 13, 2026

Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm

Aug 13, 2026

DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - tradingkey.com

Aug 13, 2026

Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com

Aug 13, 2026

Aug 12, 2026

DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com

Aug 12, 2026

DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade

Aug 12, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Aug 12, 2026

DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade

Aug 12, 2026

Aug 11, 2026

DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - quiverquant.com

Aug 11, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Aug 11, 2026

Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2026

Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - moomoo.com

Aug 11, 2026

DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Aug 11, 2026

Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan

Aug 11, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire

Aug 11, 2026

Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan

Aug 11, 2026

$Dermata Therapeutics (DRMA.US)$ - moomoo.com

Aug 11, 2026

Aug 07, 2026

Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView

Aug 07, 2026

Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - kalkine.com.au

Aug 07, 2026

Aug 06, 2026

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com

Aug 06, 2026

Aug 05, 2026

Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks

Aug 05, 2026

Dermata to launch first consumer skincare product Aug. 25 - Investing.com

Aug 05, 2026

Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa

Aug 05, 2026

Dermata's planned $178 skincare set includes four weekly treatments - Stock Titan

Aug 05, 2026

Dermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWD

Aug 05, 2026

Jul 30, 2026

Dermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingView

Jul 30, 2026

Jul 27, 2026